SETTLE® is the world’s first and only immunotherapeutic licensed to treat equine endometritis - one of the root causes of poor conception rates.
Supportive research has demonstrated positive results not only for rapidly resolving uterine infection, but also improving overall uterine health.
The USDA has approved SETTLE® as an aid in the treatment of equine endometritis caused by Streptococcus zooepidemicus.
Powerful as a stand-alone therapy, SETTLE® can be effectively integrated with standard treatment regimens that include antibiotics and uterine lavage.
Ten reasons to consider SETTLE® for your problem mares:
A new technological approach for a costly, industry-wide reproduction problem
Normalizes sub-optimal responses to infection and endometritis in problem mares
Proven both safe and effective in U.S. mares over past two breeding seasons
Works as a stand alone treatment or hand-in-hand with other therapies to synergistically improve